MEREO BIOPHARMA GROUP PL-ADR

MREONASDAQ

🏆 #3678 by market capEarnings Nov 9US Equity

$0.32▲ $0.05 (+16.32%)

Market closed · at close

1h—

24h▲ 16.3%

7d—

14d—

30d—

1y—

🏦Market Cap

$51M

Small Cap

📈Revenue Growth (YoY)

+0.0%

Slowing

📊Gross Margin

0.0%

Thin

💵FCF Margin

0.0%

Thin

⚖️P/S Ratio

0.0x

Cheap

Otter Score

55

Weak

Earnings

Q3 · 2026Reported 2026-08-11

Earnings Per Share

Actual

-0.01

Expected

-0.01

inline

+0.00%

YoY +50.00%

Revenue

Actual

—

Expected

$3.50M

—

—

Consensus estimates

Recent quarters

Q3 2026

-0.01

inline

Q2 2026

-0.01

miss

Q1 2026

-0.01

inline

Q4 2025

-0.01

miss